Research Letter
Topical diphencyprone for the treatment of locoregional intralymphatic melanoma metastases of the skin; the 5-year Norwich experience
M. Moncrieff,
M. Moncrieff
Skin Tumour Unit, Norfolk and Norwich University Hospital, Colney Lane, Norwich, NR4 7UY U.K.
Search for more papers by this author M. Fadhil,
M. Fadhil
Skin Tumour Unit, Norfolk and Norwich University Hospital, Colney Lane, Norwich, NR4 7UY U.K.
Search for more papers by this author J. Garioch,
Corresponding Author
J. Garioch
Skin Tumour Unit, Norfolk and Norwich University Hospital, Colney Lane, Norwich, NR4 7UY U.K.
Correspondence: Jennifer Garioch.
E-mail: [email protected]
Search for more papers by this author
M. Moncrieff,
M. Moncrieff
Skin Tumour Unit, Norfolk and Norwich University Hospital, Colney Lane, Norwich, NR4 7UY U.K.
Search for more papers by this author M. Fadhil,
M. Fadhil
Skin Tumour Unit, Norfolk and Norwich University Hospital, Colney Lane, Norwich, NR4 7UY U.K.
Search for more papers by this author J. Garioch,
Corresponding Author
J. Garioch
Skin Tumour Unit, Norfolk and Norwich University Hospital, Colney Lane, Norwich, NR4 7UY U.K.
Correspondence: Jennifer Garioch.
E-mail: [email protected]
Search for more papers by this author
First published: 24 November 2015
No abstract is available for this article.
References
- 1Balch CM, Gershenwald JE, Soong S-J et al. Final version of 2009 AJCC melanoma staging and classification. J Clin Oncol 2009; 27: 1–8.
- 2McCarthy WH, Shaw HM, Thompson JF, Milton GW. Time and frequency of recurrence of cutaneous stage I malignant melanoma with guidelines for follow-up study. Surg Gynecol Obstet 1988; 166: 497.
- 3Pawlik TM, Ross MI, Johnson MM et al. Predictors and natural history of in-transit melanoma after sentinel lymphadenectomy. Ann Surg Oncol 2005; 12: 587.
- 4Kretschmer L, Beckmann I, Thoms KM et al. Factors predicting the risk of in-transit recurrence after sentinel lymphonodectomy in patients with cutaneous malignant melanoma. Ann Surg Oncol 2006; 13: 1105.
- 5Borgstein PJ, Meijer S, van Diest PJ. Are locoregional cutaneous metastases in melanoma predictable? Ann Surg Oncol 1999; 6: 315.
- 6Cascinelli N, Bufalino R, Marolda R et al. Regional non-nodal metastases of cutaneous melanoma. Eur J Surg Oncol 1986; 12: 175.
- 7Calabro A, Singletary SE, Balch CM. Patterns of relapse in 1001 consecutive patients with melanoma nodal metastases. Arch Surg 1989; 124: 1051.
- 8Testori A, Faries MB, Pennacchiolo E et al. Local and intralesional therapy of in transit melanoma metastases. J Surg Oncol 2011; 104: 391–6.
- 9Damian DL, Thompson JF. Treatment of extensive cutaneous melanoma metastasis with topical diphencyprone. J Am Acad Dermatol 2007; 56: 869–71.
- 10Damian DL, Saw RPM. Dramatic regression of cutaneous, nodal and visceral melanoma metastases. J Am Acad Dermatol 2001; 65: 665–6.
- 11Damian DL, Saw RP, Thompson JF. Topical immunotherapy with diphencyprone for in transit and cutaneously metastatic melanoma. J Surg Oncol 2014; 109: 308–13.
- 12Van der Steen PHM. Topical immunotherapy of alopecia areata. Dermatol Clin 1993; 11: 619–22.
- 13Gulati N, Suárez-Fariñas M, Fuentes-Duculan J et al. Molecular characterization of human skin response to diphencyprone at peak and resolution phases: therapeutic insights. J Invest Dermatol 2014; 134: 2531–40.
